Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/44890
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodrigues, Mauricio Martins [UNIFESP]
dc.contributor.authorAlencar, Bruna Cunha Gondim de [UNIFESP]
dc.contributor.authorClaser, Carla [UNIFESP]
dc.contributor.authorTzelepis, Fanny [UNIFESP]
dc.contributor.authorSilveira, Eduardo Lani Volpe da [UNIFESP]
dc.contributor.authorHaolla, Filipe Augusto Bettencourt [UNIFESP]
dc.contributor.authorDominguez, Mariana Ribeiro [UNIFESP]
dc.contributor.authorVasconcelos, Jose Ronnie [UNIFESP]
dc.date.accessioned2018-06-18T11:04:01Z-
dc.date.available2018-06-18T11:04:01Z-
dc.date.issued2009-07-01
dc.identifierhttp://dx.doi.org/10.1590/S0074-02762009000900037
dc.identifier.citationMemorias Do Instituto Oswaldo Cruz. Rio De Janeiro, Rj: Fundaco Oswaldo Cruz, v. 104, n. S1, p. 281-287, 2009.
dc.identifier.issn0074-0276
dc.identifier.urihttp://repositorio.unifesp.br/11600/44890-
dc.description.abstractVaccines have had an unquestionable impact on public health during the last century. The most likely reason for the success of vaccines is the robust protective properties of specific antibodies. However, antibodies exert a strong selective pressure and many microorganisms, such as the obligatory intracellular parasite Trypanosoma cruzi, have been selected to survive in their presence. Although the host develops a strong immune response to T. cruzi, they do not clear the infection and instead progress to the chronic phase of the disease. Parasite persistence during the chronic phase of infection is now considered the main factor contributing to the chronic symptoms of the disease. Based on this finding, containment of parasite growth and survival may be one method to avoid the immunopathology of the chronic phase. In this context, vaccinologists have looked over the past 20 years for other immune effector mechanisms that could eliminate these antibody-resistant pathogens. We and others have tested the hypothesis that non-antibody-mediated cellular immune responses (CD4(+) Th1 and CD8(+) Tc1 cells) to specific parasite antigens/genes expressed by T. cruzi could indeed be used for the purpose of vaccination. This hypothesis was confirmed in different mouse models, indicating a possible path for vaccine development.en
dc.format.extent281-287
dc.language.isoeng
dc.publisherFundaco Oswaldo Cruz
dc.relation.ispartofMemorias Do Instituto Oswaldo Cruz
dc.rightsAcesso aberto
dc.subjectTrypanosoma cruzien
dc.subjectvaccineen
dc.subjectimmunityen
dc.titleSwimming against the current: genetic vaccination against Trypanosoma cruzi infection in miceen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.description.affiliationUniv Fed Sao Paulo, Escola Paulista Med, Ctr Interdisciplinar Terapia Gen CINTERGEN, BR-04044010 Sao Paulo, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, BR-04044010 Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Escola Paulista Med, Ctr Interdisciplinar Terapia Gen CINTERGEN, BR-04044010 Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, BR-04044010 Sao Paulo, Brazil
dc.identifier.fileS0074-02762009000900037.pdf
dc.identifier.scieloS0074-02762009000900037
dc.identifier.doi10.1590/S0074-02762009000900037
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000269123500036
Appears in Collections:Artigo
Artigo

Files in This Item:
File SizeFormat 
S0074-02762009000900037.pdf580.03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.